Commentary:
Commentary on the NICE Guideline on Tolvaptan for treating autosomal dominant polycystic kidney disease (ADPKD)
This guideline has been archived. It may contain outdated
information.
Read More
Publication Date:
01/06/2016
Review Date: 01/06/2023
Review Date: 01/06/2023